@finnigan86 , thanks heaps!
Finally had a good read of this most revealing interview:
1, " 70% gross margin"
( on US$100 to $125/unit)
2, With 53% of vested interest & control, Dr Yakov Genva will max wealth creation all shhs
(Top 30 incl mgt holds >90%, of 340m sh+ops, i think)
3, English is not his first languange, as noted by some posters on previous occasions,
hence his answers may give the impression of "wishy-washy"; but not the case.
(PR training or support required? =)
4, When he is ready to retire in 5 or 10 years, the likely successor is Nir Geva (CTO), a son or nephew, co-inventor and patent-holders of Gmed devices
5, Gmed is not a trader stock.
That's the way it will 'behave' given what we observed of the stock movements over last 3-4 months.
6, When the stars (news, progress updates) in next 4-8-12 weeks are aligned, sp will be 'allowed' to move, faster.
We are in good hands. Aimo. Dyor.
*
